GSK3B and osteosarcoma: GSK-3β inhibitors also induced the nuclear translocation of β-catenin in osteosarcoma cells, whereas the nuclear localization of β-catenin was constitutively observed in hFOB1.19 osteoblasts regardless of treatment with DMSO or GSK-3β inhibitor (Figure 5B, Supplementary Figure S3).